Amy DiCamillo

Corporate Officer/Principal en Melior Discovery, Inc. .

Commercial Services

Consumer Services

Cargos activos de Amy DiCamillo

Empresas	Cargo	Inicio	Fin
Melior Discovery, Inc. Melior Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Melior Discovery, Inc. provides phenotypic screening, in vivo pharmacology, drug abuse liability and seizure potential services. It offers theraTRACE, an indications discovery platform of multiplexed in vivo models that focus on various indications/therapeutic areas, including neurodegenerative disease and psychiatry, inflammation, acute and chronic pain, metabolic disease, gastrointestinal & urology, cardiovascular disease, and dermatology aspects. The company was founded by Andrew G. Reaume and Michael S. Saporito in 2005 and is headquartered in Exton, PA.	Corporate Officer/Principal	-	-
	Director Técnico/Científico/I+D	-	-

West Chester University of Pennsylvania

Graduate Degree

Internacional

Estados Unidos

Operativa

Chief Tech/Sci/R&D Officer	1
Corporate Officer/Principal	1
Graduate Degree	1

Sectorial

Commercial Services	2
Consumer Services	2

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas privadas	1
Melior Discovery, Inc. Melior Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Melior Discovery, Inc. provides phenotypic screening, in vivo pharmacology, drug abuse liability and seizure potential services. It offers theraTRACE, an indications discovery platform of multiplexed in vivo models that focus on various indications/therapeutic areas, including neurodegenerative disease and psychiatry, inflammation, acute and chronic pain, metabolic disease, gastrointestinal & urology, cardiovascular disease, and dermatology aspects. The company was founded by Andrew G. Reaume and Michael S. Saporito in 2005 and is headquartered in Exton, PA.	Commercial Services

Empresas privadas

Commercial Services